Xiaoan Ke Selected Research

Xiaoan Ke Research Topics

2	Prolactinoma (Prolactinomas) 01/2024 - 04/2022
2	Adenoma (Adenomas) 01/2024 - 01/2020
1	Non-alcoholic Fatty Liver Disease 02/2024
1	Morbid Obesity 02/2024
1	Neoplasms (Cancer) 01/2024
1	Hyperprolactinemia 04/2023
1	Lordosis 01/2023
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2022
1	Ventricular Heart Septal Defects (Ventricular Septal Defect) 12/2021
1	Intellectual Disability (Idiocy) 12/2021
1	Ovarian Cysts (Ovarian Cyst) 12/2021
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2021
1	Hypercholesterolemia 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Obesity 01/2020
1	Acromegaly 01/2020
1	Polyuria 10/2019
1	Inappropriate ADH Syndrome (SIADH) 10/2019
1	Hyponatremia 10/2019
1	Dizziness (Lightheadedness) 10/2019

3	Growth Hormone (Somatotropin)IBA 01/2023 - 01/2020
2	ProlactinIBA 02/2024 - 01/2024
2	amsonic acid (DAS)IBA 01/2024 - 04/2022
2	Dopamine Agonists (Dopamine Agonist)IBA 01/2024 - 04/2022
1	Testosterone (Sustanon)FDA Link 02/2024
1	polymeric prolactin (BPRL)IBA 04/2023
1	Hormones (Hormone)IBA 01/2022
1	Coffee FDA Link 12/2021
1	LipidsIBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	LDL CholesterolIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	GlycolipidsIBA 01/2020
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2020
1	AdipokinesIBA 01/2020
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	SodiumIBA 10/2019
1	Tolvaptan FDA Link 10/2019
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 10/2019

1	Therapeutics 04/2022